Возраст домена | 23 года |
Дата окончания | Истек срок регистрации |
PR | 4 |
ИКС | |
Страниц в Google | 100 |
Страниц в Яндексе | 90 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 7078880 |
Alexa Country | Нет данных |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
Inventages | Venture Capital
n/a
n/a
UTF-8
38.42 КБ
346
2 785 симв.
2 359 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
![]() ![]() |
5 | 9 |
0 | 25 | ![]() | |
![]() ![]() |
3 | 9 |
0 | 5 | ![]() | |
![]() ![]() |
3 | 8 |
0 | 4165 | ![]() | |
![]() ![]() |
3 | 9 |
0 | 3 | ![]() | |
![]() |
3 | 6 |
0 | 1584 | ![]() | |
![]() ![]() |
3 | 8 |
0 | 563 | ![]() | |
![]() ![]() |
2 | 6 |
275 | 35684 | ![]() | |
![]() |
2 | 2 |
0 | 3037636 | ![]() |
|
![]() |
2 | 6 |
0 | 2908 | ![]() | |
![]() |
2 | 5 |
140 | 19911 | ![]() | |
![]() |
1 | 4 |
0 | 1233253 | ![]() | |
![]() |
1 | n/a | 0 | 26320042 | ![]() |
|
![]() |
1 | 2 |
0 | 14296251 | ![]() |
|
![]() ![]() |
1 | 7 |
0 | 2914 | ![]() | |
![]() |
1 | 4 |
0 | 195707 | ![]() | |
![]() |
1 | 5 |
0 | 5045124 | ![]() |
|
![]() |
1 | n/a | 0 | 4650901 | ![]() |
|
Еще 33 сайта после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
![]() | Нет доступа | Нет доступа | n/a |
Данные linkpad ( 15 Февраля 2015 ) | |
Количество ссылок на сайт | 20 |
Количество доменов, которые ссылаются на сайт | 16 |
Количество найденных анкоров | 8 |
Исходящие (внешние) ссылки домена | 53 |
Количество доменов, на которые ссылается сайт | 32 |
Количество исходящих анкоров | 43 |
Внутренние ссылки главной страницы ( 36 ) | |
# | › |
inventages.com/about-us/ | about us |
inventages.com/senior-leadership-team/ | team |
inventages.com/portfolio/ | portfolio |
inventages.com/news/ | news |
inventages.com/investment-focus/ | focus |
inventages.com/careers/ | careers |
inventages.com/contact-us/ | contact us |
inventages.com/am-pharma-an-inventages-portfolio-company-rai... | Jul 16, 2019 - AM-Pharma, an Inventages portfolio company, raises €116m to conduct a pivotal Phase III Trial of recAP in Acute ... |
inventages.com/china-national-biotec-group-cnbg-and-immunobi... | Mar 18, 2019 - China National Biotec Group (CNBG) and ImmunoBiology Ltd Enter Licensing Agreement to Co-Develop Next Generation ... |
inventages.com/jama-publishes-phase-ii-recap-data-for-sepsis... | Oct 24, 2018 - JAMA publishes Phase II recAP data for sepsis-associated Acute Kidney Injury |
inventages.com/mundipharma-closes-acquisiton-of-inventages-p... | Sep 5, 2018 - MUNDIPHARMA CLOSES ACQUISITON OF INVENTAGES PORTFOLIO COMPANY VITAL FOOD PROCESSORS LIMITED AND SECURES GLOBAL RIG... |
inventages.com/am-pharma-still-on-track-with-sepsis-drug-des... | Mar 9, 2018 - AM-Pharma still on track with sepsis drug despite mixed phase 2 readout |
inventages.com/am-pharma-announces-phase-ii-study-results-of... | Mar 9, 2018 - AM-Pharma announces Phase II study results of recAP in sepsis-associated Acute Kidney Injury |
inventages.com/phagenesis-has-successfully-reached-the-first... | Oct 4, 2017 - Phagenesis has successfully reached the first of two milestones in its staged acquisition agreement with Nestlé He... |
inventages.com/atonomics-announces-ce-marking-of-trace-lipid... | May 31, 2017 - Atonomics announces CE marking of Trace Lipids Test Panel |
inventages.com/am-pharma-completes-patient-recruitment-of-re... | May 22, 2017 - AM-Pharma completes patient recruitment of recombinant human Alkaline Phosphatase |
inventages.com/accera-appoints-dr-judith-walker-as-chief-med... | May 3, 2017 - Accera Appoints Dr. Judith Walker as Chief Medical Officer |
inventages.com/project/accera/ | <img> |
inventages.com/project/am-pharma/ | <img> |
inventages.com/project/atonomics/ | <img> |
inventages.com/project/cognoptix/ | <img> |
inventages.com/project/gc-rise/ | <img> |
inventages.com/project/horizon/ | <img> |
inventages.com/project/immbio/ | <img> |
inventages.com/project/msi/ | <img> |
inventages.com/project/biosys-health/ | <img> |
inventages.com/project/opsona/ | <img> |
inventages.com/project/phagenesis/ | <img> |
inventages.com/project/phosphate/ | <img> |
inventages.com/project/phytomedics/ | <img> |
inventages.com/project/shield/ | <img> |
inventages.com/project/steaz/ | <img> |
inventages.com/project/velle/ | <img> |
inventages.com/project/vital-foods/ | <img> |
inventages.com/project/xo/ | <img> |
Domain Name: INVENTAGES.COM
Registry Domain ID: 43482033_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.1and1.com
Registrar URL: http://registrar.1and1.info
Updated Date: 2018-03-12T17:36:53Z
Creation Date: 2000-11-19T07:54:50Z
Registry Expiry Date: 2018-11-19T07:54:50Z
Registrar: 1&1 Internet SE
Registrar IANA ID: 83
Registrar Abuse Contact Email: abuse@1and1.com
Registrar Abuse Contact Phone: +1.6105601459
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS1102.UI-DNS.BIZ
Name Server: NS1102.UI-DNS.COM
Name Server: NS1102.UI-DNS.DE
Name Server: NS1102.UI-DNS.ORG
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-10-27T14:22:59Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
User-agent: *
Disallow: /wp-admin/
Allow: /wp-admin/admin-ajax.php
HTTP/1.1 200 OK
Content-Type: text/html; charset=UTF-8
Transfer-Encoding: chunked
Connection: keep-alive
Keep-Alive: timeout=15
Date: Sun, 29 Dec 2019 06:34:15 GMT
Server: Apache
X-Powered-By: PHP/7.2.25
Link: ; rel="https://api.w.org/", ; rel=shortlink
Expires: Thu, 19 Nov 1981 08:52:00 GMT
Cache-Control: no-store, no-cache, must-revalidate
Pragma: no-cache
Set-Cookie: PHPSESSID=63d6ee5d7adb7182cfd37ae54702042e; path=/
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"